UK Health Check-up Market
UK Health Check-up (Blood, Urine, Body Fluid, Imaging) Market Size, Share & Trends Analysis Report 2024-2030
August 20, 2024 09:33 ET | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "UK Health Check-up Market Size, Share & Trends Analysis Report By Test Type (Blood, Urine, Body Fluid Tests, Imaging-based Tests), By End-use...
U.S. ADHD And Autism Clinics Market
U.S. ADHD And Autism Clinics Market Research 2024-2030: Advancements in Treatment Options & Growing Government Support & Funding
August 20, 2024 09:21 ET | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. ADHD And Autism Clinics Market Size, Share & Trends Analysis Report By Condition (Attention Deficit Hyperactivity Disorder (ADHD), Autism...
U.S. Healthcare Training And Education Services Outsourcing Market
U.S. Healthcare Training and Education Services Outsourcing Market Trends Analysis Report 2024-2030
August 20, 2024 09:16 ET | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Healthcare Training And Education Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Training and Development,...
North American Citric Acid Market
North America Citric Acid Market Report 2024-2032
August 20, 2024 09:07 ET | Research and Markets
Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "North America Citric Acid Market Report by Application (Food and Beverages, Household Detergents and Cleaners, Pharmaceuticals, and Others), Form...
Logo_brown_2.png
Reborn Coffee Provides Second Quarter 2024 Corporate Update and Financial Results
August 20, 2024 08:31 ET | REBORN COFFEE, INC.
Reborn Coffee Provides Second Quarter 2024 Corporate Update and Financial Results
AIMLogo.jpg
AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
August 20, 2024 08:30 ET | AIM ImmunoTech Inc.
Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential of Ampligen and...
DZS-Dark-Blue.jpg
DZS Files Q1 2024 Financial Results
August 20, 2024 08:03 ET | DZS
DALLAS, Aug. 20, 2024 (GLOBE NEWSWIRE) -- DZS (OTC: DZSI), a developer of Network Edge, Connectivity and Cloud Software solutions enabling gigabit broadband everywhere, today announced that it has...
nano-logo (002).jpg
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
August 20, 2024 08:00 ET | Nano-X Imaging LTD.
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
GeoVax.png
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
August 20, 2024 07:45 ET | GeoVax, Inc.
ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
Oroco Announces 22.2
Oroco Announces 22.2% After-tax IRR and $1.48 Billion NPV for its Santo Tomas Project
August 20, 2024 07:42 ET | Oroco Resource Corp.
Vancouver, Canada, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Oroco Resource Corporation. (“Oroco” or the “Company”) (TSXV: OCO; OTCQB: ORRCF, BF: OR6) is pleased to announce a revised Preliminary Economic...